Lindley C
School of Pharmacy, University of North Carolina, Chapel Hill 27599-7360.
Am Pharm. 1991 May;NS31(5):46-51. doi: 10.1016/s0160-3450(16)33731-x.
This review presents an overview of a heterogeneous group of disorders that fall under the general heading of lymphomas. Many specific subtypes and presentations exist; their presentations, treatments, and prognoses vary greatly. Patients with lymphomas are generally treated with external beam radiation therapy, chemotherapy, or a combination of these two modalities. The community pharmacist may play an important role in management of patients by recognizing and alleviating the distressing side effects of treatment. Unfortunately, prevention and early detection play little role in the management of lymphomas. The improvement in survival rates of patients with all but indolent NHL is a direct result of advances in chemotherapy.
本综述概述了归类于淋巴瘤这一总体范畴的一组异质性疾病。存在许多特定的亚型和表现形式；它们的表现、治疗方法和预后差异很大。淋巴瘤患者通常接受外照射放疗、化疗或这两种方式的联合治疗。社区药剂师通过识别并减轻治疗带来的令人痛苦的副作用，可能在患者管理中发挥重要作用。不幸的是，预防和早期检测在淋巴瘤的管理中作用甚微。除惰性非霍奇金淋巴瘤外，所有淋巴瘤患者生存率的提高是化疗进展的直接结果。
